发明名称 Pharmaceutical Composition Comprising Lumiracoxib
摘要 Disclosed herein are tablets and methods of treatment comprising the administration of such tablets. The tablets are immediate release tablets that comprise about 400 mg of 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid or a pharmaceutically acceptable salt thereof, where the 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid or a pharmaceutically acceptable salt thereof comprises between 60 and 70% by weight of the tablet. The methods involve the administration of the tablets of the invention to individuals in need of administration of such tablets.
申请公布号 KR100895551(B1) 申请公布日期 2009.04.29
申请号 KR20047002925 申请日期 2002.08.30
申请人 发明人
分类号 A61K9/20;A61K31/196;A61K;A61K9/22;A61K31/195;A61K47/12;A61K47/32;A61K47/36;A61K47/38;A61P;A61P29/00;A61P43/00;C07C;(IPC1-7):A61K31/196 主分类号 A61K9/20
代理机构 代理人
主权项
地址